We are live on ! Find out more
WE

Wealth Effects Portfolio holdings

AUM $282M
1-Year Est. Return 62.81%
This Fund
S&P 500
This Quarter Est. Return
+5.44%
1 Year Est. Return
+62.81%
3 Year Est. Return
+160.11%
5 Year Est. Return
10 Year Est. Return
AUM
$241M
AUM Growth
Cap. Flow
+$245M
Cap. Flow %
101.71%
Top 10 Hldgs %
38.78%
Holding
215
New
215
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
AVDL
Avadel Pharmaceuticals
AVDL
+$21.1M
2
AAPL icon
Apple
AAPL
+$17.2M
3
ARWR icon
Arrowhead Research
ARWR
+$10M
4
AMZN icon
Amazon
AMZN
+$10M
5
NVDA icon
NVIDIA
NVDA
+$7.41M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 26.05%
2 Healthcare 24.9%
3 Communication Services 10.01%
4 Financials 9.77%
5 Consumer Discretionary 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARKW icon
126
ARK Web x.0 ETF
ARKW
$1.64B
$369K 0.15%
+3,114
New +$440K
F icon
127
Ford
F
$56.7B
$369K 0.15%
+17,758
New +$327K
AVGO icon
128
Broadcom
AVGO
$1.76T
$362K 0.15%
+5,430
New +$305K
CHD icon
129
Church & Dwight Co
CHD
$23.2B
$359K 0.15%
+3,506
New +$318K
ROBO icon
130
ROBO Global Robotics & Automation Index ETF
ROBO
$1.9B
$358K 0.15%
+5,104
New +$349K
TSCO icon
131
Tractor Supply
TSCO
$16B
$358K 0.15%
+7,500
New +$328K
SOLN
132
DELISTED
The Southern Company
SOLN
$357K 0.15%
+6,650
New +$344K
DAL icon
133
Delta Air Lines
DAL
$55.4B
$356K 0.15%
+9,100
New +$364K
COIN icon
134
Coinbase
COIN
$41.4B
$342K 0.14%
+1,357
New +$395K
EW icon
135
Edwards Lifesciences
EW
$49.4B
$340K 0.14%
+2,625
New +$306K
RTX icon
136
RTX Corp
RTX
$261B
$331K 0.14%
+3,852
New +$336K
PVLA
137
Palvella Therapeutics
PVLA
$2.26B
$330K 0.14%
+1,091
New +$349K
CSX icon
138
CSX Corp
CSX
$94.3B
$325K 0.13%
+8,646
New +$305K
DOCN icon
139
DigitalOcean
DOCN
$12.4B
$320K 0.13%
+3,988
New +$373K
UPS icon
140
United Parcel Service
UPS
$100B
$319K 0.13%
+1,489
New +$303K
WFC icon
141
Wells Fargo
WFC
$265B
$319K 0.13%
+6,649
New +$327K
MRVL icon
142
Marvell Technology
MRVL
$169B
$315K 0.13%
+3,600
New +$269K
BCS icon
143
Barclays
BCS
$93.8B
$311K 0.13%
+30,000
New +$315K
BDSI
144
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$311K 0.13%
+100,300
New +$338K
FYC icon
145
First Trust Small Cap Growth AlphaDEX Fund
FYC
$1.43B
$310K 0.13%
+4,155
New +$312K
MO icon
146
Altria Group
MO
$124B
$307K 0.13%
+6,475
New +$297K
GE icon
147
GE Aerospace
GE
$364B
$303K 0.13%
+5,154
New +$324K
CB icon
148
Chubb
CB
$137B
$299K 0.12%
+1,549
New +$291K
UNP icon
149
Union Pacific
UNP
$179B
$298K 0.12%
+1,183
New +$280K
FYX icon
150
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.36B
$296K 0.12%
+3,055
New +$294K

Similar funds

Wealth Effects's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Wealth Effects, which disclosed 215 positions worth $241M. Its ten largest holdings account for 39% of the portfolio.

Its largest position is Avadel Pharmaceuticals: 2,305,017 shares worth $18.6M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, followed by Healthcare and Communication Services.

  • Wealth Effects's largest Q4 2021 buy was Avadel Pharmaceuticals: 2,305,017 shares worth $18.6M.
  • Wealth Effects's ten largest holdings make up 39% of its $241M portfolio in Q4 2021.
  • Wealth Effects disclosed 215 positions in Q4 2021, its first 13F filing on record.

Based on Wealth Effects's 13F filing for Q4 2021, filed 9 Feb 2022.